Here are three things to know about Dr. Weet:
1. Dr. Weet has over 40 years of experience in regulatory affairs, including oversight of U.S. Food and Drug Administration relations in the area of ocular disease.
2. Previously, he served as the vice president of regulatory affairs and quality assurance at Collegium Pharmaceutical, and as the vice president of global regulatory affairs at Bausch + Lomb.
3. At Bausch + Lomb, Dr. Weet worked on the regulatory submission for Besivance, a drug for the treatment of bacterial conjunctivitis.
More articles on supply chain:
Supply chain tip of the day: Take advantage of the cloud
How ASCs can be held liable for 3D medical devices — And 5 strategies to avoid risk
Supply chain tip of the day: Use mobile apps in the ordering process
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.